日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inflammatory bowel diseases in the elderly population: epidemiology, long-term disease course, surgery rates, and biological use-data from the Veszprem county cohort between 1977 and 2020

老年人群炎症性肠病:流行病学、长期病程、手术率和生物制剂使用情况——来自维斯普雷姆县队列1977年至2020年的数据

Angyal, Dorottya; Gonczi, Lorant; Balogh, Fruzsina; Wetwittayakhlang, Panu; Golovics, Petra A; Pandur, Tunde; David, Gyula; Erdelyi, Zsuzsanna; Szita, Istvan; Ilias, Akos; Lakatos, Laszlo; Lakatos, Peter L

Incidence, disease course, therapeutic strategies and outcomes of inflammatory bowel disease-unclassified patients in Western Hungary: A population-based cohort

匈牙利西部未分类炎症性肠病患者的发病率、疾病进程、治疗策略和预后:一项基于人群的队列研究

Balogh, Fruzsina; Gonczi, Lorant; Angyal, Dorottya; Golovics, Petra Anna; Pandur, Tunde; David, Gyula; Erdelyi, Zsuzsanna; Szita, Istvan; Ilias, Akos; Lakatos, Laszlo; Lakatos, Peter Laszlo

Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn's disease patients over three years

乌司奴单抗治疗克罗恩病患者三年疗效、药物可持续性和安全性

Barkai, Laszlo J; Gonczi, Lorant; Balogh, Fruzsina; Angyal, Dorottya; Farkas, Klaudia; Farkas, Bernadett; Molnar, Tamas; Szamosi, Tamas; Schafer, Eszter; Golovics, Petra A; Juhasz, Mark; Patai, Arpad; Vincze, Aron; Sarlos, Patricia; Farkas, Alexandra; Dubravcsik, Zsolt; Toth, Tamas G; Szekely, Hajnal; Miheller, Pal; Lakatos, Peter L; Ilias, Akos

Association Between Serum Ustekinumab Concentrations and Endoscopic Disease Activity in Moderate-to-Severe Crohn's Disease Patients

血清乌司奴单抗浓度与中重度克罗恩病患者内镜下疾病活动度的相关性

Di Fonzo, David M P; Alabdulkarim, Balqis; Yanofsky, Russell; Abduallah, Yaqeen; Golovics, Petra; Lakatos, Peter L; Bitton, Alain; Wild, Gary; Afif, Waqqas; Bessissow, Talat

Declining Trends of Reoperations and Disease Behaviour Progression in Crohn's Disease over Different Therapeutic Eras-A Prospective, Population-Based Study from Western Hungary between 1977-2020, Data from the Veszprem Cohort

不同治疗时期克罗恩病再次手术率和疾病进展的下降趋势——一项来自匈牙利西部地区(1977-2020 年)的前瞻性人群研究,数据来自维斯普雷姆队列

Gonczi, Lorant; Lakatos, Laszlo; Golovics, Petra A; Ilias, Akos; Pandur, Tunde; David, Gyula; Erdelyi, Zsuzsanna; Szita, Istvan; Al Khoury, Alex; Lakatos, Peter L

Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977-2020

40 年来炎症性肠病患者环境和社会经济风险因素的时间趋势:一项基于人群的队列研究(1977-2020 年)

Wetwittayakhlang, Panu; Gonczi, Lorant; Golovics, Petra A; Kurti, Zsuzsanna; Pandur, Tunde; David, Gyula; Erdelyi, Zsuzsanna; Szita, Istvan; Lakatos, Laszlo; Lakatos, Peter L

Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn's Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study

阿达木单抗治疗小肠克罗恩病黏膜愈合和临床疗效(SIMCHA 研究):一项前瞻性、开放标签、单臂研究的最终结果

Wetwittayakhlang, Panu; Verdon, Christine; Starr, Michael; Hahn, Gustavo Drügg; Golovics, Petra A; Bessissow, Talat; Afif, Waqqas; Wild, Gary; Bitton, Alain; Lakatos, Peter L

P717 Faecal Microbiota Transplant in Ulcerative Colitis (FMTUC) – A randomised clinical trial feasibility study

P717 粪便微生物移植治疗溃疡性结肠炎 (FMTUC) – 一项随机临床试验可行性研究

Desai, Bhavik; Svirsky, John; Dussias, N; Carbone, A; Melotti, L; Privitera Hrustemovic, H; Salice, M; Scaioli, E; Calabrese, C; Rizzello, F; Gionchetti, P; Shafrir, A; Benson, A A; Zinger, A; Shauli Aharonov, M; Katz, L H; Wetwittayakhlang, P; Albader, F; Golovics, P; Drügg Hahn, G; Bessissow, T; Bitton, A; Afif, W; Wild, G; Lakatos PhD, P L; Komeylian, H; Stewart, M; Currie, B; Phalen-Kelly, K; Heisler, C G; Jones, J; Brenner, E; Zhang, X; Agrawal, M; Ungaro, R; Colombel, J F; Kappelman, M; Farkas, K; Matuz, M; Kata, D; Földesi, I; Resál, T; Bacsur, P; Szántó, K; Kolarovszki-Erdei, D; Rutka, M; Fábián, A; Bor, R; Szepes, Z; Sarlós, P; Miheller, P; Zacháry, A; Molnár, T; Zhang, E; Gupta, A; Macrae, F A; Christensen, B; Sciberras, N; Pisani, A; Vassallo, C; Zahra Bianco, E; Ellul, P; Bezzio, C; Guarino, A D; Arena, I; Della Corte, C; Devani, M; Manes, G; Schettino, M; Sablich, E; Vernero, M; Saibeni, S; Bossa, F; Guerra, M; Carparelli, S; Antonella, M; Terracciano, F; Costantino, A; Caprioli, F; Valvano, M R; Martino, G; Nardella, M; Perri, F; Sharma, S; Jones, J; Stewart, M; Horvath, M; Csontos, Á A; Sárközi, M; Cseprekal, O; Szijártó, A; Miheller, P; Jitsumura, M; Cunningham, A; Hitchings, M D; Wilkinson, T; Kinross, J; Row, P; Davies, A; Dean Anthony, H

Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study

生物制剂在老年炎症性肠病患者中的有效性、安全性和药物可持续性:一项回顾性研究

Hahn, Gustavo Drügg; LeBlanc, Jean-Frédéric; Golovics, Petra Anna; Wetwittayakhlang, Panu; Qatomah, Abdulrahman; Wang, Anna; Boodaghians, Levon; Liu Chen Kiow, Jeremy; Al Ali, Maryam; Wild, Gary; Afif, Waqqas; Bitton, Alain; Lakatos, Peter Laszlo; Bessissow, Talat

Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?

IBD 是否有最佳的一线生物/小分子药物:我们准备好进行测序了吗?

Hahn, Gustavo Drügg; Golovics, Petra Anna; Wetwittayakhlang, Panu; Al Khoury, Alex; Bessissow, Talat; Lakatos, Peter Laszlo